Drug
Plinabulin
Plinabulin: highest development phase Phase 3, developed by BeyondSpring. 5 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BeyondSpring
Trials
| Drug | Phase | Indication |
|---|---|---|
| Plinabulin NCT03102606 | Phase 3 | Chemotherapy-induced Neutropenia |
| Plinabulin NCT07361484 | Phase 3 | Non-Small Cell Lung Cancer |
| Plinabulin NCT05130827 | Phase 2 | Multiple Myeloma |
| Plinabulin NCT04345900 | Phase 2 | Chemotherapy-induced Neutropenia |
| Plinabulin NCT04227990 | Phase 2 | Chemotherapy-induced Neutropenia |
Latest
No recent events.
Follow Plinabulin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.